DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sudarshan Pharma Industries Limited — Issue of Securities

NSE 1 hr ago·30 Oct 2026, 9:48 am

Sudarshan Pharma Industries

Sudarshan Pharma Industries Limited has informed stock exchanges about the issuance of new securities. This development indicates the company is planning to raise fresh capital, likely through a rights issue, bonus issue, or a private placement of shares.

For investors, this news signals a potential expansion of the company's equity base. It could be a move to fund new projects, reduce debt, or strengthen its financial position. However, the dilution of existing shareholders' stake is a factor to consider.

Investors should watch for the specific details of the issue, such as the price and the purpose of the funds. Monitoring the company's future financial performance will be key to understanding the long-term impact of this capital raise.